发明名称 Inhibition of dynamin related protein 1 to promote cell death
摘要 The present invention relates to compositions and methods for reducing cell proliferation and/or promoting cell death by inhibiting Drp1. It is based, at least in part, on the discoveries that (i) Drp1 disruption-induced mitochondrial hyperfusion is functionally linked to the cell cycle regulation apparatus, so that Drp1 inhibition results in a disruption of the cell cycle and DNA aberrancies; (ii) inhibition of both Drp1 and ATR are synthetic lethal causing increased DNA damage and apoptotic cell death; and (iii) even in resistant cell lines, Drp1 inhibitor (e.g., mdivi-1) together with a second antiproliferative agent (e.g., cisplatin or carboplatin) act synergistically to promote apoptosis. Accordingly, the present invention provides for novel anticancer strategies.
申请公布号 US8759097(B2) 申请公布日期 2014.06.24
申请号 US201213450345 申请日期 2012.04.18
申请人 University of Pittsburgh—of the Commonwealth System of Higher Eduction 发明人 Qian Wei;Van Houten Bennett
分类号 A61K31/517;A61P35/00;A61K38/38;C12N5/09 主分类号 A61K31/517
代理机构 Baker Botts, LLP 代理人 Baker Botts, LLP
主权项 1. A method for reducing cancer cell proliferation or promoting cancer cell death by administering, to a cancer cell, an effective amount of
地址 Pittsburgh PA US